{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T10:35:52Z","timestamp":1756809352211,"version":"3.41.0"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1023\/a:1015336831407","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T23:08:17Z","timestamp":1041116897000},"page":"205-219","source":"Crossref","is-referenced-by-count":4,"title":["Aldosterone Receptor Blockade in the Management of Heart Failure"],"prefix":"10.1007","volume":"7","author":[{"given":"Emiliano A.","family":"Palmieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadette","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serafino","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"404344_CR1","volume-title":"1998 Heart and Stroke Statistical Update","author":"American Heart Association.","year":"1997","unstructured":"American Heart Association. 1998 Heart and Stroke Statistical Update. Dallas, TX, American Heart Association, 1997."},{"issue":"suppl","key":"404344_CR2","first-page":"6A","volume":"22","author":"KKL Ho","year":"1993","unstructured":"Ho KKL, Pinskly JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993;22(suppl):6A\u201313A.","journal-title":"J Am Coll Cardiol"},{"key":"404344_CR3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archinte.1990.00390160043010","volume":"150","author":"JK Ghali","year":"1990","unstructured":"Ghali JK, Cooper R, Ford E. Trends in hospitalization for heart failure in the United States, 1973-1986: evidences for increasing population prevalence. Arch Intern Med 1990;150:769\u2013773.","journal-title":"Arch Intern Med"},{"key":"404344_CR4","first-page":"S107","volume":"13","author":"JB O'Connell","year":"1994","unstructured":"O'Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994;13:S107\u2013S112.","journal-title":"J Heart Lung Transplant"},{"key":"404344_CR5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2796.1995.tb01153.x","volume":"237","author":"H Eriksson","year":"1995","unstructured":"Eriksson H. Heart failure: a growing health problem. J Intern Med 1995;237:135\u2013141.","journal-title":"J Intern Med"},{"key":"404344_CR6","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-101-3-370","volume":"101","author":"GS Francis","year":"1984","unstructured":"Francis GS, Goldsmith SR, Levine TB, Olivari MT, Cohn JN. The neurohormonal axis in congestive heart failure. Ann Intern Med 1984;101:370\u2013377.","journal-title":"Ann Intern Med"},{"key":"404344_CR7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0735-1097(92)90016-G","volume":"20","author":"M Parker","year":"1992","unstructured":"Parker M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992;20:248\u2013254.","journal-title":"J Am Coll Cardiol"},{"key":"404344_CR8","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","volume":"316","author":"CONSENSUS Trial Study Group.","year":"1987","unstructured":"CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429\u20131435.","journal-title":"N Engl J Med"},{"key":"404344_CR9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","volume":"325","author":"The SOLVD Investigators.","year":"1991","unstructured":"The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991;325:293\u2013302.","journal-title":"N Engl J Med"},{"key":"404344_CR10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJM199108013250502","volume":"325","author":"JN Cohn","year":"1991","unstructured":"Cohn JN, Johnson G, Ziesche J, Frederick C, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, Bhat G, Goldman S, Fletcher RD, Doherty J, Hughes CV, Carson P, Cintron G, Shabetai R, Haakenson C. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991:325:303\u2013310.","journal-title":"N Engl J Med"},{"key":"404344_CR11","first-page":"821","volume":"342","author":"AIRE Study Group.","year":"1993","unstructured":"AIRE Study Group. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821\u2013828.","journal-title":"Lancet"},{"key":"404344_CR12","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","volume":"333","author":"L Kober","year":"1995","unstructured":"Kober L, Torp-Pederson C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videbaek J, Cole DS, Auclert L, Pauly NC, Aliot E, Persson S, Camm AJ, for the Trandolapril Cardiac Evaluation (TRACE) Study Group. A clinical trial of angiotensin-convertingenzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995;333:1670\u20131676.","journal-title":"N Engl J Med"},{"key":"404344_CR13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1677\/joe.0.0910457","volume":"91","author":"J Staessen","year":"1981","unstructured":"Staessen J, Lijnen P, Fagard R, Verschueren LJ, Amery A. Rise in plasma concentration of aldosterone during long term angiotensin II suppression. J Endocrinol 1981;91:457\u2013465.","journal-title":"J Endocrinol"},{"key":"404344_CR14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/hrt.52.5.530","volume":"52","author":"JG Cleland","year":"1984","unstructured":"Cleland JG, Dargie HJ, Hodsman GP, Ball SG, Robertson JI, Morton JJ, East BW, Robertson I, Murray GD, Gillen G. Captopril in heart failure: a double blind controlled trial. Br Heart J 1984; 52:530\u2013535.","journal-title":"Br Heart J"},{"key":"404344_CR15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/j.1552-4604.1993.tb03901.x","volume":"33","author":"C Barghi","year":"1993","unstructured":"Barghi C, Boschi S, Ambrosini E, Melandri G, Branzi A, Magnaru B. Evidence of partial escape of RAA blockade in patient with acute Ml treated with ACE inhibitors. J Clin Pharmacol 1993;33:40\u201345.","journal-title":"J Clin Pharmacol"},{"key":"404344_CR16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00005344-199302000-00015","volume":"21","author":"JC Aldigier","year":"1993","unstructured":"Aldigier JC, Huang H, Dalmay F, Lartigue M, Baussant T, Chassain AP, Leroux-Robert C, Galen FX. ACE inhibition does not suppress plasma All increase during exercise in humans. J Cardiovasc Pharmacol 1993;21:289\u2013295.","journal-title":"J Cardiovasc Pharmacol"},{"key":"404344_CR17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/hrt.82.1.57","volume":"82","author":"RJ MacFadyen","year":"1999","unstructured":"MacFadyen RJ, Lee AF, Morton JJ, Pringle SD, Struthers AD. How often are angiotensin II and aldosterone raised during chronic ACE inhibitor treatment in cardiac failure? Heart 1999;82: 57-61.","journal-title":"Heart"},{"key":"404344_CR18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1388-9842(99)00046-X","volume":"1","author":"AF Lee","year":"1999","unstructured":"Lee AF, MacFayden RJ, Struthers AD. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study. Eur J Heart Failure 1999;1:401\u2013406.","journal-title":"Eur J Heart Failure"},{"key":"404344_CR19","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","volume":"82","author":"K Swedberg","year":"1990","unstructured":"Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormone regulating cardiovascular function in Aldosterone Receptor Blockade in Heart Failure 215 patients with severe heart failure and their relation to mortality. Circulation 1990;82:1730\u20131736.","journal-title":"Circulation"},{"key":"404344_CR20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1172\/JCI117322","volume":"94","author":"R Studer","year":"1994","unstructured":"Studer R, Reinecke H, Mueller B, Holtz J, Just H, Drexler H. Increased angiotensin-I converting enzyme gene expression in the failing human heart. J Clin Invest 1994;94:301\u2013310.","journal-title":"J Clin Invest"},{"key":"404344_CR21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/01.RES.80.2.219","volume":"80","author":"A Wolny","year":"1997","unstructured":"Wolny A, Clozel J-P, Rein J, Mory P, Vogt P, Turino M, Kiowski W, Fischli W. Functional and biochemical analysis of angiotensin II-forming pathways in the human heart. Circ Res 1997;80:219\u2013227.","journal-title":"Circ Res"},{"key":"404344_CR22","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.CIR.101.8.844","volume":"101","author":"UP Jorde","year":"2000","unstructured":"Jorde UP, Ennezat PV, Lisker BA, Suryadevara V, Infeld J, Cukon S, Hammer A, Sonnenblick EH, Le Jemtel TH. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure. Circulation 2000;101:844\u2013846.","journal-title":"Circulation"},{"key":"404344_CR23","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(00)02213-3","volume":"355","author":"B Pitt","year":"2000","unstructured":"Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized trial-the Losartan Heart Failure Survival Study ELITE II. Lancet 2000;355:1582\u20131587.","journal-title":"Lancet"},{"key":"404344_CR24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J, for the Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New Engl J Med 1999;341:709\u2013717.","journal-title":"New Engl J Med"},{"key":"404344_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-83120-1_1","volume":"29","author":"J M\u00fc ller","year":"1988","unstructured":"M\u00fc ller J. Regulation of aldosterone biosynthesis: physiological and clinical aspects. Monogr Endocrinol 1988:29:1\u2013364.","journal-title":"Monogr Endocrinol"},{"key":"404344_CR26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1210\/jcem-25-2-219","volume":"25","author":"JF Tait","year":"1965","unstructured":"Tait JF, Bougas J, Little B, Tait SAS, Flood C. Splanchnic extraction and clearance of aldosterone in subjects with minimal and marked cardiac dysfunction. J Clin Endocrinol 1965;25:219\u2013228.","journal-title":"J Clin Endocrinol"},{"key":"404344_CR27","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","volume":"82","author":"GS Francis","year":"1990","unstructured":"Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990;82:1724\u20131729.","journal-title":"Circulation"},{"key":"404344_CR28","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/0002-9149(82)90243-0","volume":"49","author":"TB Levine","year":"1982","unstructured":"Levine TB, Francis GS, Goldsmith SR, Simon SR, Cohn JN. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 1982;49:1659\u20131666.","journal-title":"Am J Cardiol"},{"key":"404344_CR29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1161\/01.CIR.80.2.299","volume":"80","author":"IS Anand","year":"1989","unstructured":"Anand IS, Ferrari R, Kalra GS, Wahi PL, Poole-Wilson PA, Harris PC. Edema of cardiac origin: studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive heart failure. Circulation 1989;80:299\u2013305.","journal-title":"Circulation"},{"key":"404344_CR30","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.CIR.25.6.1015","volume":"25","author":"JH Laragh","year":"1962","unstructured":"Laragh JH. Hormones and the pathogenesis of congestive heart failure: vasopressin, aldosterone, and angiotensin II: further evidence for renal-adrenal interaction form studies in hypertension and cirrhosis. Circulation 1962;25:1015\u20131023.","journal-title":"Circulation"},{"key":"404344_CR31","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1172\/JCI104545","volume":"41","author":"CR Ayers","year":"1962","unstructured":"Ayers CR, Davis JO, Lieberman F, Carpenter CCJ, Berman M. The effects of chronic hepatic venous congestion on the metabolism of d,l-aldosterone and d-aldosterone. J Clin Invest 1962;41:884\u2013895.","journal-title":"J Clin Invest"},{"key":"404344_CR32","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1172\/JCI119249","volume":"99","author":"S Okubo","year":"1997","unstructured":"Okubo S, Niimura F, Nishimura H, Takemoto F, Fogo A, Matsusaka T, Ichikawa I. Angiotensin-independent mechanism for aldosterone synthesis during chronic extracellular fluid volume depletion. J Clin Invest 1997;99:855\u2013860.","journal-title":"J Clin Invest"},{"key":"404344_CR33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1677\/joe.0.0430315","volume":"43","author":"JR Knox","year":"1969","unstructured":"Knox JR, Lockett MF. Similarity between a substance produced by the heart in vitro and the 18-monoacetyl derivative of D-aldosterone. J Endocrinol 1969;43:315\u2013316.","journal-title":"J Endocrinol"},{"key":"404344_CR34","doi-asserted-by":"crossref","first-page":"24316","DOI":"10.1016\/S0021-9258(19)51084-5","volume":"269","author":"H Hatakeyama","year":"1994","unstructured":"Hatakeyama H, Miyamori I, Fujita T, Takeda Y, Takeda R, Yamamaoto H. Vascular aldosterone. Biosynthesis and a link to angiotensin II induced hypertrophy of vascular smooth muscle cells. J Biol Chem 1994;269:24316\u201324320.","journal-title":"J Biol Chem"},{"key":"404344_CR35","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1074\/jbc.273.9.4883","volume":"273","author":"JS Silvestre","year":"1998","unstructured":"Silvestre JS, Robert V, Heymes C, Aupetit-Faisant B, Mouas C, Moalic JM, Swynghedauw B, Delcayre C. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem 1998;273:4883\u20134891.","journal-title":"J Biol Chem"},{"key":"404344_CR36","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/01.HYP.25.2.170","volume":"25","author":"Y Takeda","year":"1995","unstructured":"Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Blair IA, Hsieh FY, Takeda R. Production of aldosterone in isolated rat blood vessels. Hypertension 1995;25:170\u2013173.","journal-title":"Hypertension"},{"key":"404344_CR37","first-page":"2797","volume":"81","author":"Y Takeda","year":"1996","unstructured":"Takeda Y, Miyamori I, Yoneda T, Hatakeyama H, Inaba S, Furukawa K, Mabuchi H, Takeda R. Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin. J Clin Endocrinol Metab 1996;81:2797\u20132800.","journal-title":"J Clin Endocrinol Metab"},{"key":"404344_CR38","first-page":"195","volume":"28","author":"P Corvol","year":"1998","unstructured":"Corvol P, Schutz S, Gasc JM. Early expression of all components of the renin-angiotensin system in human development. Adv Nephrol Nacker Hosp 1998;28:195\u2013212.","journal-title":"Adv Nephrol Nacker Hosp"},{"key":"404344_CR39","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1161\/01.CIR.96.1.220","volume":"96","author":"AH Danser","year":"1997","unstructured":"Danser AH, Van Kats JP, Verdouw PD, Schatekamp MA. Evidence for the existence of a functional cardiac renin-angiotensin system in humans. Circulation 1997;96:3795\u20133796.","journal-title":"Circulation"},{"key":"404344_CR40","doi-asserted-by":"crossref","first-page":"C838","DOI":"10.1152\/ajpcell.1992.263.4.C838","volume":"263","author":"DE Dostal","year":"1992","unstructured":"Dostal DE, Rothblum KN, Chernin Ml, Cooper GR, Baker KM. Intracardiac detection of angiotensinogen and renin: a localized renin-angiotensin system in neonatal rat heart. Am J Physiol 1992;263:C838\u2013C850.","journal-title":"Am J Physiol"},{"key":"404344_CR41","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.99.20.2694","volume":"99","author":"JS Silvestre","year":"1999","unstructured":"Silvestre JS, Heymes C, Oub\u00e9na\u00efssa A, Robert V, Aupetit-Faisant B, Carayon A, Swynghedauw B, Delcayre C. Activation of cardiac aldosterone production in rat myocardial infarction. Effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 1999;99:2694\u20132701.","journal-title":"Circulation"},{"key":"404344_CR42","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","volume":"83","author":"DJ Mangelsdorf","year":"1995","unstructured":"Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, et al. The nuclear receptor superfamily: the second decade. Cell 1995;83:835\u2013839.","journal-title":"Cell"},{"key":"404344_CR43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00232796","volume":"144","author":"F Verrey","year":"1995","unstructured":"Verrey F. Transcriptional control of sodium transport in tight epithelia by adrenal steroids. J Membrane Biol 1995;144:93\u2013110.","journal-title":"J Membrane Biol"},{"key":"404344_CR44","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1073\/pnas.96.5.2514","volume":"96","author":"SY Chen","year":"1999","unstructured":"Chen SY, Bhargava A, Mastroberardino L, Meijer OC, Wang J, Buse P, Firestone GL, Verrey F, Pearce D. Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc Natl Acad Aci USA 1999;96:2514\u20132519.","journal-title":"Proc Natl Acad Aci USA"},{"key":"404344_CR45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1210\/mend.13.1.0226","volume":"13","author":"C Massaad","year":"1999","unstructured":"Massaad C, Houard N, Lomb\u00e8s M, Barouki R. Modulation of human mineralcorticoid receptor function by protein kinase A. Mol Endocrinol 1999;13:57\u201365.","journal-title":"Mol Endocrinol"},{"key":"404344_CR46","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1210\/endo.138.8.5352","volume":"138","author":"A Sato","year":"1997","unstructured":"Sato A, Liu JP, Funder JW. Aldosterone rapidly represses protein kinase C activity in neonatal rat 216 Palmieri et al. cardiomyocytes in vitro. Endocrinology 1997;138: 3410\u20133416.","journal-title":"Endocrinology"},{"key":"404344_CR47","first-page":"1345","volume":"82","author":"MC Zennaro","year":"1997","unstructured":"Zennaro MC, Ferman N, Bonvalet JP, Lomb\u00e8s M. Tissue-specific expression of a and b mRNA isoforms of the human mineralcorticoid receptor in normal and pathophysiological states. J Clin Endocrinol Metab 1997;82:1345\u20131352.","journal-title":"J Clin Endocrinol Metab"},{"key":"404344_CR48","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","volume":"242","author":"JW Funder","year":"1988","unstructured":"Funder JW, Pearce PT, Smith R, Smith AI. Mineralcorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 1988;242:583\u2013585.","journal-title":"Science"},{"key":"404344_CR49","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(88)90742-8","volume":"2","author":"CRW Edwards","year":"1988","unstructured":"Edwards CRW, Stewart PM, Burt D, Bret L, McIntyre MA, Sutanto WS, de Kloet ER, Monder C. Localization of 11\u03b2-hydroxysteroid dehydrogenasetissue specific protector of the mineralcorticoid receptor. Lancet 1988;2:986\u2013989.","journal-title":"Lancet"},{"key":"404344_CR50","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1172\/JCI114781","volume":"86","author":"JP Bonvalet","year":"1990","unstructured":"Bonvalet JP, Doignon I, Blot-Chabaud M, Pradelles P, Farman N. Distribution of 11\u03b2-hydroxysteroid dehydrogenase along the rabbit nephron. J Clin Invest 1990;86:832\u2013837.","journal-title":"J Clin Invest"},{"key":"404344_CR51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/endo-129-1-17","volume":"129","author":"A Naray-Fejes-Toth","year":"1991","unstructured":"Naray-Fejes-Toth A, Watlington CO, Fejes-Toth G. 11\u03b2-hydroxysteroid dehydrogenase in the renal target cells of aldosterone. Endocrinology 1991; 129:17\u201321.","journal-title":"Endocrinology"},{"key":"404344_CR52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.CIR.92.2.175","volume":"92","author":"M Lomb\u00e8s","year":"1995","unstructured":"Lomb\u00e8s M, Alfaidy N, Eugene E, Lessana A, Farman N, Bonvalet JP. Prerequisite for cardiac aldosterone action: mineral corticoid receptor and 11\u03b2-hydroxysteroid dehydrogenase in the human heart. Circulation 1995;92:175\u2013182.","journal-title":"Circulation"},{"key":"404344_CR53","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1006\/jmcc.1996.0072","volume":"28","author":"SH Slight","year":"1996","unstructured":"Slight SH, Ganjam VK, Gomez-Sanchez CE, Zhou MY, Weber KT. High affinity NAD(+)-dependent 11 beta-dydroxysteroid dehydrogenase in the human heart. J Mol Cell Cardiol 1996;28:781\u2013787.","journal-title":"J Mol Cell Cardiol"},{"key":"404344_CR54","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.RES.71.3.503","volume":"71","author":"M Lomb\u00e8s","year":"1992","unstructured":"Lomb\u00e8s M, Oblin ME, Gasc JM, Baulieu EE, Farman N, Bonvalet JP. Immunohistochemical and biochemical evidence for a cardiovascular mineralcorticoid receptor. Circ Res 1992;71:503\u2013510.","journal-title":"Circ Res"},{"key":"404344_CR55","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1440-1681.1987.tb02422.x","volume":"14","author":"P Pearce","year":"1987","unstructured":"Pearce P, Funder JW. High affinity aldosterone binding sites (type I receptors) in rat heart. J Clin Exp Pharmacol Physiol 1987;14:859\u2013866.","journal-title":"J Clin Exp Pharmacol Physiol"},{"key":"404344_CR56","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1210\/endo-125-4-2224","volume":"125","author":"JW Funder","year":"1989","unstructured":"Funder JW, Pearce PT, Smith R, Campbell J. Vascular type I aldosterone binding sites are physiological mineralcorticoid receptors. Endocrinology 1989;125: 2224\u20132226.","journal-title":"Endocrinology"},{"key":"404344_CR57","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0022-4731(81)90046-7","volume":"14","author":"WJ Meyer","year":"1981","unstructured":"Meyer WJ, Nichols N. Mineralcorticoid binding in cultured smooth muscle cells and fibroblast from rat aorta. J Steroid Biochem 1981;14:1157\u20131168.","journal-title":"J Steroid Biochem"},{"key":"404344_CR58","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1046\/j.1523-1755.2000.00974.x","volume":"57","author":"H Hatakeyama","year":"2000","unstructured":"Hatakeyama H, Inaba S, Takeda R, Miyamori I. 11beta-hydroxysteroid dehydrogenase in human vascular cells. Kidney Int 2000;57:1352\u20131357.","journal-title":"Kidney Int"},{"key":"404344_CR59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1291\/hypres.24.33","volume":"24","author":"H Hatakeyama","year":"2001","unstructured":"Hatakeyama H, Inaba S, Miyamori I. 11beta-hydroxysteroid dehydrogenase activity in human aortic smooth muscle cells. Hypertens Res 2001;24:33\u201337.","journal-title":"Hypertens Res"},{"key":"404344_CR60","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1006844010371","volume":"189","author":"SH Slight","year":"1998","unstructured":"Slight SH, Chilakamarri VK, Nasr S, Dhalla AK, Ramires FJ, Sun Y, Ganjam VK, Weber KT. Inhibition of tissue repair by spironolactone: role of mineralcorticoids in fibrous tissue formation. Mol Cell Biochem 1998;189:47\u201354.","journal-title":"Mol Cell Biochem"},{"key":"404344_CR61","first-page":"549","volume":"53","author":"JP Bonvalet","year":"1998","unstructured":"Bonvalet JP. Regulation of sodium transport by steroid hormone. Kidney Int 1998;53:549\u2013556.","journal-title":"Kidney Int"},{"key":"404344_CR62","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1172\/JCI112723","volume":"78","author":"RJ Cody","year":"1986","unstructured":"Cody RJ, Atlas SA, Laragh JH, Kubo SH, Covit AB, Ryman KS, Shaknovich A, Pondolfino K, Clark M, Camargo MJ, et al. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma level and renal, hormonal and hemodynamic responses to peptide infusion. J Clin Invest 1986;78: 1362\u20131374.","journal-title":"J Clin Invest"},{"key":"404344_CR63","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/00005344-198611000-00003","volume":"8","author":"GA Riegger","year":"1986","unstructured":"Riegger GA, Kromer EP, Kochsiek K. Human atrial natriuretic peptide: Plasma levels, hemodynamic, hormonal and renal effects in patients with severe congestive heart failure. J Cardiovasc Pharmacol 1986;8:1107\u20131112.","journal-title":"J Cardiovasc Pharmacol"},{"key":"404344_CR64","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1210\/endo-121-1-248","volume":"121","author":"J Ding","year":"1987","unstructured":"Ding J, Thibault G, Gutkowska J, Garcia R, Karabatsos T, Jasmin G, Genest J, Cantin M. Cardiac and plasma atrial natriuretic factor in experimental congestive heart failure. Endocrinology 1987;121: 248\u2013257.","journal-title":"Endocrinology"},{"key":"404344_CR65","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/0024-3205(87)90294-3","volume":"40","author":"RW Lee","year":"1987","unstructured":"Lee RW, Gay RG, Moffett C, Johnson DG, Goldman S. Atrial natriuretic peptide levels during development of chronic heart failure after myocardial infarction in rats. Life Sci 1987;40:2025\u20132030.","journal-title":"Life Sci"},{"key":"404344_CR66","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0014-2999(87)90804-1","volume":"140","author":"T Tikkanen","year":"1987","unstructured":"Tikkanen T, Svartstrom-Fraser M, Tikkanen I, Sariola H, Fyhrquist F. Hemodynamic effects of atrial natriuretic peptide in rats with heart failure. Eur J Pharmacol 1987;140:187\u2013193.","journal-title":"Eur J Pharmacol"},{"key":"404344_CR67","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/01.CIR.73.6.1155","volume":"73","author":"ER Bates","year":"1986","unstructured":"Bates ER, Shenker Y, Grekin RJ. The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man. Circulation 1986;73:1155\u20131161.","journal-title":"Circulation"},{"key":"404344_CR68","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(86)92675-9","volume":"2","author":"LG Crozier","year":"1986","unstructured":"Crozier LG, Nicholls MG, Ikram H. Hemodynamic effects of atrial peptide infusion in heart failure. Lancet 1986;2:1242\u20131245.","journal-title":"Lancet"},{"key":"404344_CR69","first-page":"Fl46","volume":"252","author":"CL Davis","year":"1987","unstructured":"Davis CL, Briggs JP. Effect of reduction in renal artery pressure on atrial natriuretic peptide-induced natriuresis. Am J Physiol 1987;252:Fl46\u2013Fl53.","journal-title":"Am J Physiol"},{"key":"404344_CR70","first-page":"R917","volume":"257","author":"MM Redfield","year":"1989","unstructured":"Redfield MM, Edwards BS, Heublein DM, Burnett JC Jr. Restoration of renal response to atrial natriuretic factor in experimental low-output heart failure. Am J Physiol 1989;257:R917\u2013R923.","journal-title":"Am J Physiol"},{"key":"404344_CR71","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1042\/cs0740213","volume":"74","author":"EL Schiffrin","year":"1988","unstructured":"Schiffrin EL. Decreased density of binding sites for atrial natriuretic peptide on platelets of patients with severe congestive heart failure. Clin Sci (Colch) 1988;74:213\u2013218.","journal-title":"Clin Sci (Colch)"},{"key":"404344_CR72","first-page":"R858","volume":"261","author":"Z Abassi","year":"1991","unstructured":"Abassi Z, Burnett JC Jr, Grushka E, Hoffman A, Haramati A, Winaver J. Atrial natriuretic peptide and renal cGMP in rats with experimental heart failure. Am J Physiol 1991;261:R858\u2013R864.","journal-title":"Am J Physiol"},{"key":"404344_CR73","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1172\/JCI115180","volume":"87","author":"MA Perrella","year":"1991","unstructured":"Perrella MA, Margulies KB, Wei CM, Aarhus LL, Heublein DM, Burnett JC Jr. Pulmonary and urinary clearance of atrial natriuretic factor in acute congestive heart failure in dogs. J Clin Invest 1991;87:1649\u20131655.","journal-title":"J Clin Invest"},{"key":"404344_CR74","doi-asserted-by":"crossref","first-page":"F562","DOI":"10.1152\/ajpcell.1991.260.3.C562","volume":"260","author":"KB Margulies","year":"1991","unstructured":"Margulies KB, Heublein DM, Perrella MA, Burnett JC Jr. ANF-mediated renal cGMP generation in congestive heart failure. Am J Physiol 1991; 260:F562\u2013F568.","journal-title":"Am J Physiol"},{"key":"404344_CR75","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1172\/JCI112368","volume":"77","author":"P Weidmann","year":"1986","unstructured":"Weidmann P, Hasler L, Gnadinger MP, Lang RE, Uehlinger DE, Shaw S, Rascher W, Reubi FC. Blood levels and renal effects of atrial natriuretic peptide in normal man. J Clin Invest 1986;77:734\u2013742.","journal-title":"J Clin Invest"},{"key":"404344_CR76","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0002-9343(77)90541-1","volume":"63","author":"AM Chonko","year":"1977","unstructured":"Chonko AM, Bay WH, Stein JH, Ferris TF. The role of renin and aldosterone in the salt retention of edema. Am J Med 1977;63:881\u2013889.","journal-title":"Am J Med"},{"key":"404344_CR77","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1172\/JCI108355","volume":"57","author":"J Bell-Reuss","year":"1976","unstructured":"Bell-Reuss J, Abraham WI, D\u00fc rr J, Schirer RW. Effect of renal sympathetic nerve stimulation on proximal water and sodium reabsorption. J Clin Invest 1976;57:1104\u20131107.","journal-title":"J Clin Invest"},{"key":"404344_CR78","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/01.RES.37.1.101","volume":"37","author":"BD Meyers","year":"1983","unstructured":"Meyers BD, Deen WM, Brenner BM. Effects of norepinephrine and angiotensin II on the determinants of Aldosterone Receptor Blockade in Heart Failure 217 glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res 1983;37:101\u2013110.","journal-title":"Circ Res"},{"key":"404344_CR79","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.7361117","volume":"208","author":"PDMV Turlapaty","year":"1989","unstructured":"Turlapaty PDMV, Altuna BM. Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death form ischemic heart disease. Science 1989;208:198\u2013200.","journal-title":"Science"},{"key":"404344_CR80","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/01.CIR.79.3.597","volume":"79","author":"H Miyagi","year":"1989","unstructured":"Miyagi H, Yasue H, Okumura K, Ogawa H, Goto K, Oshima S. Effect of magnesium on anginal attack induced by hyperventilation in patients with variant angina. Circulation 1989;79:597\u2013602.","journal-title":"Circulation"},{"key":"404344_CR81","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/0735-1097(93)90095-I","volume":"21","author":"EJ Eichhorn","year":"1993","unstructured":"Eichhorn EJ, Tandon PK, DiBianco R, Timmis GC, Fenster PE, Shannon J, Packer M. Clinical and prognostic significance of serum magnesium concentration in patients with severe CHF: the PROMISE Study. J Am Coll Cardiol 1993;21:634\u2013640.","journal-title":"J Am Coll Cardiol"},{"key":"404344_CR82","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/clc.4960190409","volume":"19","author":"V Ducceschi","year":"1996","unstructured":"Ducceschi V, Di Micco G, Sarubbi B, Russo B, Santangelo L, Iacono A. Ionic mechanisms of ischemia-related ventricular arrhythmias. Clin Cardiol 1996;19:325\u2013331.","journal-title":"Clin Cardiol"},{"key":"404344_CR83","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0002-8703(94)90514-2","volume":"127","author":"BL Bean","year":"1994","unstructured":"Bean BL, Varghese PL. Role of magnesium deficiency in the pressor and arrhythmogenic response to epinephrine in intact dog. Am Heart J 1994;127: 96\u2013102.","journal-title":"Am Heart J"},{"key":"404344_CR84","first-page":"1","volume":"88","author":"CS Barr","year":"1993","unstructured":"Barr CS, Hanson J, Kennedy N, Lang CC, Struthers AD. The effect of a mineralcorticoid antagonist on myocardial mlBG uptake in CHF. Circulation 1993;88:1\u2013256.","journal-title":"Circulation"},{"key":"404344_CR85","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/0735-1097(89)90360-4","volume":"13","author":"KT Weber","year":"1989","unstructured":"Weber KT. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 1989;13:1637\u20131652.","journal-title":"J Am Coll Cardiol"},{"key":"404344_CR86","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/ajplegacy.1968.215.6.1409","volume":"215","author":"E Morkin","year":"1968","unstructured":"Morkin E, Ashford TP. Myocardial DNA synthesis in experimental cardiac hypertrophy. Am J Physiol 1968;215:1409\u20131413.","journal-title":"Am J Physiol"},{"key":"404344_CR87","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/cvr\/22.10.686","volume":"22","author":"CW Doering","year":"1988","unstructured":"Doering CW, Jalil JE, Janicki JS, Pietra G, Fishman AP. Collagen network remodeling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res 1988;22:686\u2013695.","journal-title":"Cardiovasc Res"},{"key":"404344_CR88","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/01.RES.62.4.757","volume":"62","author":"JE Jalil","year":"1988","unstructured":"Jalil JE, Janicki JS, Pick R, Shroff SG, Weber KT. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 1988;62:757\u2013765.","journal-title":"Circ Res"},{"key":"404344_CR89","doi-asserted-by":"crossref","first-page":"1G","DOI":"10.1016\/0002-9149(90)90952-W","volume":"65","author":"KT Weber","year":"1990","unstructured":"Weber KT, Janicki JS, Pick R, Capasso J, Anversa P. Myocardial fibrosis and pathologic hypertrophy in the rat with renovascular hypertension. Am J Cardiol 1990;65:1G\u20137G.","journal-title":"Am J Cardiol"},{"key":"404344_CR90","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/01.CIR.97.17.1708","volume":"97","author":"CV Thomas","year":"1998","unstructured":"Thomas CV, Coker ML, Zellner JL, Handy JR, Crumbley JA III, Spinale FG. Increased matrix metalloproteinases activity and selective upregulation in LV myocardium form patients with end-stage heart failure. Circulation 1998;97:1708\u20131715.","journal-title":"Circulation"},{"key":"404344_CR91","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/(SICI)1097-4644(19961101)63:2<185::AID-JCB6>3.0.CO;2-U","volume":"63","author":"SC Tyagi","year":"1996","unstructured":"Tyagi SC, Kumar S, Voelker DJ, Reddy HK, Janicki JS, Curtis JJ. Differential gene expression of extracellular matrix components in dilated cardiomyopathy. J Cell Biochem 1996;63:185\u2013198.","journal-title":"J Cell Biochem"},{"key":"404344_CR92","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00714328","volume":"155","author":"SC Tyagi","year":"1996","unstructured":"Tyagi SC, Campbell SE, Reddy HK, Tjahja E, Voelker DJ. Martrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathy in human hearts. Mol Cell Biochem 1996;155:13\u201321.","journal-title":"Mol Cell Biochem"},{"key":"404344_CR93","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","volume":"67","author":"CG Brilla","year":"1990","unstructured":"Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of the rat right and left ventricle in experimental hypertension. Circ Res 1990;67:1355\u20131364.","journal-title":"Circ Res"},{"key":"404344_CR94","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","volume":"83","author":"KT Weber","year":"1991","unstructured":"Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensinaldosterone system. Circulation 1991;83:1849\u20131865.","journal-title":"Circulation"},{"issue":"supplC","key":"404344_CR95","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/eurheartj\/16.suppl_C.45","volume":"16","author":"CG Brilla","year":"1995","unstructured":"Brilla CG, Maisch B, Zhou G, Weber KT. Hormonal regulation of cardiac fibroblast function. Eur Heart J 1995;16(suppl C):45\u201350.","journal-title":"Eur Heart J"},{"key":"404344_CR96","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1006\/jmcc.1994.1098","volume":"26","author":"CG Brilla","year":"1994","unstructured":"Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblast: response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994;26:809\u2013820.","journal-title":"J Mol Cell Cardiol"},{"key":"404344_CR97","first-page":"893","volume":"120","author":"CG Brilla","year":"1992","unstructured":"Brilla CG, Weber KT. Mineralcorticoid excess, dietary sodium and myocardial fibrosis. J Lab Clin Med 1992;120:893\u2013901.","journal-title":"J Lab Clin Med"},{"issue":"5","key":"404344_CR98","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1210\/endo.141.5.7529","volume":"141","author":"Y Takeda","year":"2000","unstructured":"Takeda Y, Yoneda T, Demura M, Miyamori I, Mabuchi H. Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy. Endocrinology 2000 May;141(5):1901\u20131904.","journal-title":"Endocrinology"},{"key":"404344_CR99","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/01.RES.64.6.1041","volume":"64","author":"JE Jalil","year":"1989","unstructured":"Jalil JE, Doering CW, Janicki JS, Pick R, Shroff SG, Weber KT. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 1989;64:1041\u20131050.","journal-title":"Circ Res"},{"key":"404344_CR100","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0022-2828(88)90597-4","volume":"20","author":"JE Jalil","year":"1988","unstructured":"Jalil JE, Doering CW, Janicki JS, Pick R, Clark WA, Weber KT. J Mol Cell Cardiol 1988;20:1179\u20131187.","journal-title":"J Mol Cell Cardiol"},{"key":"404344_CR101","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/cvr\/23.8.655","volume":"23","author":"EP Carroll","year":"1989","unstructured":"Carroll EP, Janicki JS, Pick R, Weber KT. Myocardial stiffness and reparative fibrosis following coronary embolization in the rat. Cardiovasc Res 1989;23:655\u2013661.","journal-title":"Cardiovasc Res"},{"key":"404344_CR102","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/01.RES.66.5.1400","volume":"66","author":"JM Capasso","year":"1990","unstructured":"Capasso JM, Palackal T, Olivetti G, Anversa P. Left ventricular failure induced by long-term hypertension in rats. Circ Res 1990;66:1400\u20131412.","journal-title":"Circ Res"},{"issue":"suppl","key":"404344_CR103","first-page":"46A","volume":"71","author":"D Klung","year":"1993","unstructured":"Klung D, Robert V, Swynghedauw B. Role of mechanical and hormonal factors in cardiac remodeling and the biologic limits of myocardial adaptation. Am J Cardiol 1993;71(suppl):46A\u201354A.","journal-title":"Am J Cardiol"},{"key":"404344_CR104","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","volume":"25","author":"CG Brilla","year":"1993","unstructured":"Brilla CG, Matsubara LS, Weber KT. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol 1993;25:563\u2013575.","journal-title":"J Mol Cell Cardiol"},{"key":"404344_CR105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0140-6736(94)91164-9","volume":"343","author":"CS Barr","year":"1994","unstructured":"Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994;343:327\u2013329.","journal-title":"Lancet"},{"key":"404344_CR106","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","volume":"31","author":"R Rocha","year":"1998","unstructured":"Rocha R, Chander PN, Khanna K, Zuckerman A, Stier CT Jr. Mineralcorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. Hypertension 1998;31:451\u2013458.","journal-title":"Hypertension"},{"key":"404344_CR107","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0008-6363(97)00091-6","volume":"35","author":"RJ MacFadyen","year":"1997","unstructured":"MacFadyen RJ, Barr CS, Struthers. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. Cardiovasc Res 1997;35:30\u201334.","journal-title":"Cardiovasc Res"},{"key":"404344_CR108","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1053\/euhj.1998.1099","volume":"19","author":"DA Duprez","year":"1998","unstructured":"Duprez DA, De Buyzere ML, Rietzschel ER, Taes Y, Clement DL, Morgan D, Cohn JN. Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients. Eur Heart J 1998;19:1371\u20131376.","journal-title":"Eur Heart J"},{"key":"404344_CR109","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0922-4106(95)90018-7","volume":"290","author":"U Ikeda","year":"1995","unstructured":"Ikeda U, Kanbe T, Nakayama I, Kawahara Y, Yokoyama M, Shimada K. Aldosterone inhibits nitric oxide synthesis in rat vascular smooth vascular cells induced by interleukin-l\u03b2. Eur J Pharmacol 1995;290:69\u201373.","journal-title":"Eur J Pharmacol"},{"key":"404344_CR110","doi-asserted-by":"crossref","unstructured":"Weber KT, Purdy RE, Drayer JIM. Interactions between aldosterone and pressor agents in vascular smooth muscle. Hypertension 1983;(2 Pt 2):141\u2013146.","DOI":"10.1161\/01.HYP.5.2_Pt_2.I41"},{"key":"404344_CR111","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0022-4731(89)90250-1","volume":"33","author":"A Jazayer\u00ec","year":"1989","unstructured":"Jazayer\u00ec A, Meyer W. Mineralocorticoid induced increase in beta-adrenergic receptors of cultured rat arterial smooth muscle cells. J Steroid Biochem 1989;33:987\u2013991.","journal-title":"J Steroid Biochem"},{"key":"404344_CR112","doi-asserted-by":"crossref","first-page":"C1525","DOI":"10.1152\/ajpcell.1993.264.6.C1525","volume":"264","author":"ME Ullian","year":"1993","unstructured":"Ullian ME, Hutchison FN, Hazen-Martin DJ, Morinelli TA. Angiotensin II-aldosterone interaction on protein synthesis in vascular smooth muscle cells. Am J Physiol 1993;264:C1525\u2013C1531.","journal-title":"Am J Physiol"},{"key":"404344_CR113","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0002-9149(99)80353-1","volume":"76","author":"CS Barr","year":"1995","unstructured":"Barr CS, Lang CC, Hanson J, Arnott M, Kennedy N, Struthers AD. Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1995;76:1259\u20131265.","journal-title":"Am J Cardiol"},{"key":"404344_CR114","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0002-9149(96)00465-1","volume":"78","author":"The RALES Investigators.","year":"1996","unstructured":"The RALES Investigators. Effectiveness of spironolactone added to angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]). Am J Cardiol 1996; 78:902\u2013907.","journal-title":"Am J Cardiol"},{"key":"404344_CR115","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1161\/01.CIR.102.19.2325","volume":"102","author":"J Bauersachs","year":"2000","unstructured":"Bauersachs J, Fraccarollo D, Erts G, Gretz N, Wehling M, Christ M. Striking increase of natriuresis by low-dose spironolactone in congestive heart failure only in combination with ACE inhibition. Mechanistic evidence to support RALES. Circulation 2000;102:2325\u20132328.","journal-title":"Circulation"},{"key":"404344_CR116","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","volume":"101","author":"CAJ Farquharson","year":"2000","unstructured":"Farquharson CAJ, Struthers AD. Spironolactone increase nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure. Circulation 2000;101: 594\u2013597.","journal-title":"Circulation"},{"key":"404344_CR117","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1161\/01.CIR.98.24.2652","volume":"98","author":"H Drexler","year":"1998","unstructured":"Drexler H. Endothelial as therapeutic target in heart failure. Circulation 1998;98:2652\u20132655.","journal-title":"Circulation"},{"key":"404344_CR118","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0735-1097(00)00796-8","volume":"36","author":"T Tsutamoto","year":"2000","unstructured":"Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Horie H, Sugimoto Y, Kinoshita M. Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure. J Am Coll Cardiol 2000;36:838\u2013844.","journal-title":"J Am Coll Cardiol"},{"key":"404344_CR119","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","volume":"102","author":"F Zannad","year":"2000","unstructured":"Zannad F, Alla F, Dousset B, Perez A, Pitt B, on behalf of the RALES Investigators. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure. Insights from the Randomized Aldactone Evaluation Study (RALES). Circulation 2000;102:2700\u20132706.","journal-title":"Circulation"},{"key":"404344_CR120","first-page":"3","volume-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","author":"LZ Benet","year":"1990","unstructured":"Benet LZ, Mitchell JR, Sheiner LB. Pharmacokinetics: the dynamics of drug absorption, distribution, and elimination. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed. New York: Pergamon Press, Inc., 1990:3\u201332.","edition":"8th ed."},{"key":"404344_CR121","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1071-9164(99)91340-4","volume":"5","author":"Guidelines Committee Membersthe Executive Council for the Heart Failure Society of America.","year":"1999","unstructured":"Guidelines Committee Members and the Executive Council for the Heart Failure Society of America. HFSA Guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction-Pharmacological approaches. J Card Fail 1999;5:357\u2013382.","journal-title":"J Card Fail"},{"key":"404344_CR122","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM199908193410806","volume":"341","author":"RW Schrier","year":"1999","unstructured":"Schrier RW, Abrham WT. Hormone and hemodynamics in heart failure. N Engl J Med 1999;341: 577\u2013585.","journal-title":"N Engl J Med"},{"key":"404344_CR123","unstructured":"Aldactone: spironolactone. In: Physicians' desk reference. 53rd ed. Montvale, N.J.: Medical Economics, 1999:2928\u20132929."},{"key":"404344_CR124","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2265.1985.tb01090.x","volume":"23","author":"D Armanini","year":"1985","unstructured":"Armanini D, Karbowiak I, Goi A, Mantero F, Founder W. In-vivo metabolites of spironolactone and potassium canreonate: determination of potential anti-androgenic activity by a mouse kidney cytosol receptor assay. Clin Endocrinol 1985;23:341\u2013347.","journal-title":"Clin Endocrinol"},{"key":"404344_CR125","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0022-3565(25)22580-0","volume":"240","author":"M de Gasparo","year":"1987","unstructured":"de Gasparo M, Joss U, Ramjoue HP, Whitebread SE, Haenni H, Schenkel L, Kraehenbuehl C, Biollaz M, Grob J, Schmidlin J, et al. Three new epoxy-spironolactone derivative: characterization in vivo and in vitro. J Pharmacol Exp Ther 1987;240:650\u2013656.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1015336831407.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1015336831407\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1015336831407.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:34:26Z","timestamp":1747996466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1015336831407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":125,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["404344"],"URL":"https:\/\/doi.org\/10.1023\/a:1015336831407","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"type":"print","value":"1382-4147"},{"type":"electronic","value":"1573-7322"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}